semaglutide with metformin vs Efficacy and safety of once-weekly semaglutide versus daily canagliflozin as add-on to metformin in patients type 2 diabetes (SUSTAIN 8): a double-blind, phase 3b, randomised controlled trial PDF) Research Progress of Semaglutide

Model-based evaluation of exenatide effects on the QT interval in healthy subjects following continuous IV infusion

Common gastrointestinal side effects of tirzepatide include nausea, vomiting, and diarrhea, particularly during dose escalation

Participants using Tirzepatide experienced on average a 20.2% reduction in body weight over approximately 72 weeks, whereas those on Semaglutide saw about a 13.7% decrease

Randomised clinical trial: Design of the SYNERGY-NASH phase 2b trial to evaluate tirzepatide as a treatment for metabolic dysfunction-associated steatohepatitis and modification of screening strategy to reduce screen failures

The tone is a steady decline from recent highs, and the momentum signals broadly confirm this pronounced weakness